Wegovy price in Korea: what you actually pay for

What determines the Wegovy price in Korea

When people search for the Wegovy price in Korea, they often find a single figure for one pen. In practice, what you pay over a treatment course depends on several parts working together: the medicine itself, the medical assessment that makes it safe to prescribe, and the follow-up that adjusts your dose over time.

Wegovy is semaglutide, a once-weekly injection approved for chronic weight management. It was launched in Korea in late 2024. Because it is a prescription medicine, every course starts with a consultation, and the price you are quoted at VEI Clinic reflects the plan built for you rather than a generic package.

• Your dose step: Wegovy starts at a low dose and increases roughly every four weeks toward a maintenance dose, and pen prices differ by strength
• Pen supply: each pen covers a set number of weekly doses, so the number of pens depends on how long your plan runs and how often you return
• Consultation: the initial medical assessment with Dr. Park and the injection teaching session
• Tests: baseline blood tests and a body composition test, chosen according to your health history
• Follow-ups: review visits to check side effects, adjust the dose and monitor progress

Why the cost changes over time

The first months of Wegovy follow a titration schedule: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and then 2.4 mg weekly. Not everyone reaches or needs the top dose. Some people stay at a lower step because it works well for them or because higher doses cause side effects. Your monthly cost may therefore rise during the step-up phase and then settle once a maintenance dose is found.

Treatment length also matters. Wegovy is designed as a long-term medicine, and weight regain is common after stopping. When planning your budget, it helps to think in terms of several months rather than a single pen. We discuss realistic timelines during your consultation.

Is Wegovy covered by Korean national health insurance?

When prescribed for weight management, Wegovy is generally not covered by the National Health Insurance Service (NHIS), so it is paid out of pocket. Some of the blood tests or consultations linked to a diagnosed medical condition may be handled differently, and we will tell you clearly what applies in your case.

If you hold private or international health insurance, coverage for obesity medicines varies widely. We can provide an itemized receipt and medical documents in English that you can submit to your insurer, but we cannot guarantee reimbursement.

Who Wegovy suits, and who should not use it

Paying for a medicine only makes sense if it is right for you. Wegovy is generally intended for adults with a BMI of 30 or more, or 27 or more with a weight-related condition such as high blood pressure, prediabetes or high cholesterol. It is not recommended for people with a personal or family history of medullary thyroid carcinoma or MEN2, during pregnancy or breastfeeding, or for those with a history of pancreatitis without careful review.

If Dr. Park finds that Wegovy is not appropriate, he will explain why and discuss alternatives, which may include a different medicine, treatment of an underlying issue such as thyroid disease, or a lifestyle-focused plan. You will not be charged for medicine that is not prescribed.

Be cautious with very cheap offers

Because demand is high, you may see Wegovy sold online, through social media or without a consultation. In Korea, Wegovy must be prescribed by a doctor and dispensed through proper channels. Pens bought from unofficial sources may be counterfeit, stored at the wrong temperature or not suitable for your health. A low headline price that skips the medical assessment can cost far more if side effects are missed.

Wegovy pens need refrigeration before first use. If you plan to travel, ask us about storage and carrying pens safely so your medicine is not wasted.